Table 1. G-CSF treatment schedules.

Formulation	Route	Dose	Frequency	Duration
Lenograstim	Subcutaneous	150 μg m–2	Daily	28 consecutive days
Filgrastim	Subcutaneous	5 μg kg–1	Daily	Up to 38 days
Pegfilgrastim	Subcutaneous	6 mg–1	Once per cycle	Once per cycle